The PPARγ agonist rosiglitazone stimulates ENaC-mediated AFC through the PPARγ/SGK1 signaling pathway to mitigate pulmonary edema in a mouse model of ALI. This evidence concerns the gene SGK1 and acute respiratory distress syndrome.